Status:
ENROLLING_BY_INVITATION
Pulmonary Hypertension Inspiratory Training
Lead Sponsor:
University of Arizona
Conditions:
Pulmonary Hypertension
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is examining the effects of six weeks of inspiratory muscle strength training (IMST) on outcomes related to pulmonary hypertension. This study leverages previous cardiopulmonary exercise te...
Detailed Description
PH is a condition characterized by abnormally high blood pressure in the lungs (i.e., pulmonary arterial pressure), which impacts heart function and reduces exercise tolerance. This study will assess ...
Eligibility Criteria
Inclusion
- Diagnosed with PH defined by clinical guideline criteria
- Must already be scheduled for a clinical assessment of their PH within 8 weeks of enrolling in the study.
- Must have undergone an assessment of their PH in the last 18 months with no major changes in PH management or medication within that period.
Exclusion
- Current smoker or have smoked in the last 10 years
- Unable or unwilling to undergo routine functional testing of their PH (i.e., 6-minute walk distance).
- Presence of significant cardiovascular or respiratory conditions other than PH, including but not limited to:
- Chronic obstructive pulmonary disease
- Severe asthma
- Severe ischemic heart disease
- Left-sided heart failure
- History of a major cardiovascular event, such as a myocardial infarction or stroke, within the last 6 months
- Individuals with an implanted pacemaker or other significant cardiac devices
- History of neurological, respiratory, head and neck, or thoracic surgeries, or conditions such as a collapsed lung or perforated eardrum
- Pregnant individuals or those actively trying to become pregnant
- Individuals with any of the following: chronic laryngitis, chronic bronchitis, emphysema, pneumonia, tuberculosis, chronic cough, extremely high blood pressure (\>170/100), neurological problems, scoliosis, organ transplants, HIV or other immunocompromising conditions, or autoimmune disease.
Key Trial Info
Start Date :
October 25 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT06931886
Start Date
October 25 2025
End Date
October 1 2026
Last Update
December 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Arizona
Tucson, Arizona, United States, 85711